Compare Gigacloud Technology Inc (GCT) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gigacloud Technology Inc vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Gigacloud Technology Inc trades at $56.77 (market cap $2.02B), while Halozyme Therapeutics Inc. Common Stock trades at $112.19 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 6.2× Gigacloud Technology Inc's market cap, and Halozyme Therapeutics Inc. Common Stock is more actively traded (2,179,278 versus 1,020,985). Which is the better fit depends on your goals — on Pluang, investors hold Gigacloud Technology Inc for 21 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| GCT | HALO | |
|---|---|---|
Market Cap | $2.02B | $12.58B |
Volume | 1,020,985 | 2,179,278 |
Sector | Technology | Health |
52-Week High | $56.42 | $115.22 |
52-Week Low | $25.46 | $61.63 |
Typical Hold Time | 21 Days | 0 Days |
Enterprise Value | $2.14B | $14.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GigaCloud Technology (GCT) trades at $55.65, down 0.55% on the day, with a bullish technical outlook from moving averages and a consensus analyst rating of Buy. The stock shows strong fundamentals with a P/E of 13.44, net income margin of 10.65%, and consistent earnings beats in recent quarters. Revenue is projected to grow from $1.29B in 2025 to $1.5B in 2026, while operating cash flow remains robust at $190.66M.
The investment outlook is positive given valuation attractiveness and earnings momentum, but risks include insider selling and reliance on international expansion. Analyst price targets suggest potential upside to $32.50 consensus, though the current price exceeds this, indicating mixed signals. Key catalysts are EU market growth and continued execution against guidance.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Gigacloud Technology Inc
Gigacloud Technology operates a global B2B e-commerce marketplace for large-parcel goods. It provides a comprehensive solution for furniture manufacturers and retailers with integrated logistics and fulfillment.
Read more on GCT →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
